Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(60%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
20%
Ph not_applicable
3
60%
Ph phase_3
1
20%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(2)

Detailed Status

Active, not recruiting2
Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (20.0%)
Phase 31 (20.0%)
N/A3 (60.0%)

Trials by Status

recruiting120%
active_not_recruiting240%
completed240%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DEVICE
Total Trials
5